Wollenhaupt J, Silverfield J, Bong Lee E, et al. Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 9 Years. ACR 2017, abstract 522.
Definiëren van renale remissie bij 248 patiënten met lupusnefritis
dec 2021 | SLE